Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Low-Dose Aspirin Safety, CVD Efficacy “Superior” To Higher Doses – McNeil

This article was originally published in The Tan Sheet

Executive Summary

Low-dose aspirin in the range of 81 mg-162 mg has a superior bleeding profile and similar efficacy to higher OTC doses for cardiovascular protection, Eric Topol, MD, Cleveland Clinic Foundation, told the FDA's Nonprescription Drugs Advisory Committee
Advertisement

Related Content

Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin CVD Indication On OTC Labeling Urged By FDA’s Jenkins
Aspirin CVD Indication On OTC Labeling Urged By FDA’s Jenkins
Aspirin CVD Indication On OTC Labeling Urged By FDA’s Jenkins
Aspirin CVD Indication On OTC Labeling Urged By FDA’s Jenkins
Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning
Bayer, McNeil St. Joseph Aspirin Ad Dispute Moves To Federal Court
Bayer, McNeil St. Joseph Aspirin Ad Dispute Moves To Federal Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS094591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel